Variants in GLP1R (the GLP-1 receptor itself), GIPR (GIP receptor particularly rs1800437, the headline variant for differential GLP-1 response), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide
PinheiroRTTrettimJPde MatosMBPinheiroKATda SilvaRAMartinsCRet alBrief cognitive behavioral therapy in pregnant women at risk of postpartum depression: pre-post therapy study in a city in southern Brazil
New acylcarnitine ratio as a reliable indicator of long-chain 3-Hydroxyacyl-CoA dehydrogenase deficiency
Strength (2-3x weekly when ready): Bodyweight exercises or light resistance
When it modulates brain signaling, you simply want less food
67% of Omada members remained on their GLP-1 medications for one year, surpassing the 47-49% persistence rate of comparable studies